Skip to main content

Table 1 Schedule of enrolment, variables and measures

From: Personalised informed choice on evidence and controversy on mammography screening: study protocol for a randomized controlled trial

Timepoint   Trial period
Enrollment Allocation Post-allocation
Baseline 0 Post (7–10 days after randomization)
Registration and signed informed consent X   
Allocation   X  
Demographics X   
Use of internet X   
Experience with other screenings X   
Previous mammography X   
Previous participation in screening programmes X   
Family history of breast cancer X   
Perceived risk of breast cancer X   
Knowledge of breast cancer screening X   X
Attitude to breast cancer screening X   X
Intention regarding breast cancer screening X   X
Satisfaction and acceptability of the information received    X
Decisional conflict    X